Clinical Trials Directory

Trials / Unknown

UnknownNCT01321489

A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies

A Clinical Phase III, Comparative, Open, Multicenter, Prospectively, to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet, Compared to Viagra ® 50mg Tablet Coated, in the Treatment of Erectile Dysfunction of Different Etiologies

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
78 (estimated)
Sponsor
Laboratório Teuto Brasileiro S/A · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the tolerability and safety of Sildenafil Citrate 20mg Sublingual tablet, as well as a possible superiority expressed by the faster onset of action compared to Viagra ® 50mg tablet Coated in erectile dysfunction.

Detailed description

Phase III clinical trial, comparative, open, multicenter, prospectively, with random inflow of 78 patients evaluable male patients with erectile dysfunction with IIEF-5 score in between 13 and 24, corresponding to mild or mild to moderate to evaluate the efficacy and safety as well as a possible superiority expressed by the faster onset of action onset of action of study medication.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil Citrate 20mg Tablet SublingualAdminister one tablet of Sildenafil Citrate 20 mg sublingually 10 minutes before intercourse. It is recommended that the administration of just one tablet a day. The patient will receive six tablets of the medication.
DRUGViagra ® 50mg tablet CoatedAdminister one tablet of Viagra ® 50mg tablet Coated orally 1 hour before intercourse. It is recommended that the administration of just one tablet a day. The patient will receive six tablets of the medication.

Timeline

Start date
2011-09-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-03-23
Last updated
2011-03-23

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01321489. Inclusion in this directory is not an endorsement.